Immunocore Company Profile

Aggregated data from the web about Immunocore

Company Name	Immunocore
Website	https://www.biospace.com
Snippet	Feb 25, 2022 · About Immunocore Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, autoimmune, and infectious disease.
Type	Private
Founded	2008
Website	www.immunocore.com
Founders	Dr. Bent Jakobsen and James Noble
Industry	Biotechnology
Products	Cancer drugs/treatments using T-Cell receptor technology
Key people	Andrew Hotchkiss, CEO; Jonathan Knowles, Chairman; Nicholas Cross, Deputy Chairman of the Board; Eva-Lotta Allan, Chief Business Officer
Headquarters	Abingdon-on-Thames , United Kingdom

Immunocore is part of the United Kingdom company list

Immunocore is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.